BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28728297)

  • 1. [The prognosis and clinicopathological characteristics of 70 gastric cancer patients with elevated serum AFP].
    Wang YK; Shen L; Zhang XT
    Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):514-517. PubMed ID: 28728297
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP.
    Wang YK; Shen L; Jiao X; Zhang XT
    World J Gastroenterol; 2018 Jan; 24(2):266-273. PubMed ID: 29375212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High level of serum AFP is an independent negative prognostic factor in gastric cancer.
    Chen Y; Qu H; Jian M; Sun G; He Q
    Int J Biol Markers; 2015 Nov; 30(4):e387-93. PubMed ID: 26349668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer.
    Liu X; Sheng W; Wang Y
    J Surg Oncol; 2012 Sep; 106(3):299-303. PubMed ID: 22389029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic features of gastric cancers producing alpha-fetoprotein.
    Kono K; Amemiya H; Sekikawa T; Iizuka H; Takahashi A; Fujii H; Matsumoto Y
    Dig Surg; 2002; 19(5):359-65; discussion 365. PubMed ID: 12435906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathological characteristics and prognosis of alpha-fetoprotein producing gastric cancer].
    Lew DH; Jung WT; Kim HJ; Min HJ; Ha CY; Kim HJ; Kim TH; Ko GH
    Korean J Gastroenterol; 2013 Dec; 62(6):327-35. PubMed ID: 24365731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic Change in Serum Alpha-fetoprotein Level Predicts Treatment Response and Prognosis of Alpha-fetoprotein-producing Gastric Cancer.
    Wang R; Li J; Xu D; Li R; Gong P
    Medicine (Baltimore); 2020 Nov; 99(47):e23326. PubMed ID: 33217870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-fetoprotein (AFP) elevation gastric adenocarcinoma and importance of AFP change in tumor response evaluation.
    Tatli AM; Urakci Z; Kalender ME; Arslan H; Tastekin D; Kaplan MA
    Asian Pac J Cancer Prev; 2015; 16(5):2003-7. PubMed ID: 25773802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [AFP-producing gastric cancer and hepatoid gastric cancer].
    Wang YK; Zhang XT
    Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):801-807. PubMed ID: 29151285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver metastasis is the only independent prognostic factor in AFP-producing gastric cancer.
    Hirajima S; Komatsu S; Ichikawa D; Kubota T; Okamoto K; Shiozaki A; Fujiwara H; Konishi H; Ikoma H; Otsuji E
    World J Gastroenterol; 2013 Sep; 19(36):6055-61. PubMed ID: 24106406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of clinical characteristics and prognosis for patients with serum alpha-fetoprotein-positive gastric cancer.
    Zuo CT; Ju Q
    Minerva Med; 2015 Aug; 106(4):185-91. PubMed ID: 26418320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of modified docetaxel-cisplatin-5-fluorouracil regimen as first-line treatment in patients with alpha-fetoprotein producing gastric carcinoma.
    Bozkaya Y; Doğan M; Yazıcı O; Erdem GU; Demirci NS; Zengin N
    Bosn J Basic Med Sci; 2017 May; 17(2):138-143. PubMed ID: 28273032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-fetoprotein-producing early gastric cancer of the remnant stomach: report of a case.
    Shibata Y; Sato K; Kodama M; Nanjyo H
    Surg Today; 2007; 37(11):995-9. PubMed ID: 17952534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
    Kim JH; Jun KH; Jung H; Park IS; Chin HM
    Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emphasis on the clinical relationship between alpha-fetoprotein and hepatoid adenocarcinoma of the stomach: a retrospective study.
    Li L; Yang X; Ji W; Zhu Q; Yang X; Niu J; Li W
    BMC Gastroenterol; 2023 May; 23(1):142. PubMed ID: 37161409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological aggressiveness of alpha-fetoprotein (AFP)-positive gastric cancer.
    Ishigami S; Natsugoe S; Nakashima H; Tokuda K; Nakajo A; Okumura H; Matsumoto M; Nakashima S; Hokita S; Aikou T
    Hepatogastroenterology; 2006; 53(69):338-41. PubMed ID: 16795967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologial features of gastric hepatoid adenocarcinoma.
    Lin CY; Yeh HC; Hsu CM; Lin WR; Chiu CT
    Biomed J; 2015; 38(1):65-9. PubMed ID: 25163499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological and prognostic features of hepatoid adenocarcinoma of the stomach.
    Zhang JF; Shi SS; Shao YF; Zhang HZ
    Chin Med J (Engl); 2011 May; 124(10):1470-6. PubMed ID: 21740800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: analysis of 104 cases.
    Liu X; Cheng Y; Sheng W; Lu H; Xu Y; Long Z; Zhu H; Wang Y
    J Surg Oncol; 2010 Sep; 102(3):249-55. PubMed ID: 20740583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathologic features and prognosis of 51 patients with α-fetoprotein-producing gastric cancer].
    Liu X; Yang M; Gao J; Zhang S; Xi Y
    Zhonghua Zhong Liu Za Zhi; 2015 Mar; 37(3):231-4. PubMed ID: 25975796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.